Schizophrenia as a Disorder of Molecular Pathways
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Over the last decade transcriptome studies of postmortem tissue from subjects with schizophrenia revealed that synaptic, mitochondrial, immune system, GABA-ergic and oligodendrocytic changes are all integral parts of the disease process. The combined genetic and transcriptomics studies argue that the molecular underpinnings of the disease are even more varied than the symptomatic diversity of schizophrenia. Ultimately, to decipher the pathophysiology of human disorders in general, we will need to understand the function of hundreds of genes and regulatory elements in our genome, and the consequences of their overexpression and reduced expression in a developmental context. Furthermore, integration of knowledge from various data sources remains a monumental challenge that has to be systematically addressed in the upcoming decades. In the end, our success in interpreting the molecular changes in schizophrenia will depend on our ability to understand the biology using innovative ideas and cannot depend on the hope of developing novel, more powerful technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 1×
“uncertain, it appears that synaptic (7,8), mitochondrial (9,10), immune system (6,11), gamma-aminobutyric acid (GABA)ergic (12,13), and oligodendrocytic (14,15) messenger RNA (mRNA) changes are all integral parts of the disease process (1,16).”
BackgroundGenome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
Lazarov, O., Robinson, J., Tang, Y.-P., Hairston, I. S., Korade-Mirnics, Z., Lee, V. M.-Y., Hersh, L. B., Sapolsky, R. M., Mirnics, K., & Sisodia, S. S. (2005) · Cell · doi:10.1016/j.cell.2005.01.015 · Cited by 885
Self-citationMirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Self-citationThe environment and susceptibility to schizophrenia
Brown, A. S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.003 · Cited by 664
Gulsuner, S., Walsh, T., Watts, A. C., Lee, M. K., Thornton, A. M., Casadei, S., Rippey, C., Shahin, H., Braff, D., Cadenhead, K. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.049 · Cited by 536
Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002011 · Cited by 490 · cited 1×
“uncertain, it appears that synaptic (7,8), mitochondrial (9,10), immune system (6,11), gamma-aminobutyric acid (GABA)ergic (12,13), and oligodendrocytic (14,15) messenger RNA (mRNA) changes are all integral parts of the disease process (1,16).”
BackgroundSelf-citationMitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Clay, H. B., Daws, S., & Konradi, C. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.007 · Cited by 399 · cited 1×
“uncertain, it appears that synaptic (7,8), mitochondrial (9,10), immune system (6,11), gamma-aminobutyric acid (GABA)ergic (12,13), and oligodendrocytic (14,15) messenger RNA (mRNA) changes are all integral parts of the disease process (1,16).”
BackgroundAdolescent Stress–Induced Epigenetic Control of Dopaminergic Neurons via Glucocorticoids
Niwa, M., Jaaro-Peled, H., Tankou, S., Seshadri, S., Hikida, T., Matsumoto, Y., Cascella, N. G., Kano, S.-I., Ozaki, N., Nabeshima, T., et al. (2013) · Science · doi:10.1126/science.1226931 · Cited by 318 · cited 1×
“In addition, a mild isolation stress affects the mesocortical projection of dopaminergic neurons, but only when combined with a relevant genetic risk for neuropsychiatric disorders (36).”
BackgroundCurley, A. A., Arion, D., Volk, D. W., Asafu-Adjei, J. K., Sampson, A. R., Fish, K. N., & Lewis, D. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010052 · Cited by 283 · cited 1×
“For example, glutamate decarboxylase 1 (GAD1)/glutamate decarboxylase 67 (GAD67) underexpression appears to be a hallmark of the illness (25), and present in the majority of the subjects with the disease—yet, this cannot be explained by genetic susceptibility in the GAD1 gene itself— lifestyle, medication history, or…”
BackgroundDiverse types of genetic variation converge on functional gene networks involved in schizophrenia
Gilman, S. R., Chang, J., Xu, B., Bawa, T. S., Gogos, J. A., Karayiorgou, M., & Vitkup, D. (2012) · Nature Neuroscience · doi:10.1038/nn.3261 · Cited by 200 · cited 1×
“are a cumulative readout of different genetic susceptibilities and environmental insults, which converge onto common molecular (and ultimately functional cellular) pathways (5,27).”
BackgroundRichards, A. L., Jones, L., Moskvina, V, Kirov, G., Gejman, P. V., Levinson, D. F., Sanders, A. R., Molecular Genetics of Schizophrenia Collaboration (MGS), International Schizophrenia Consortium (ISC), Purcell, S., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.11 · Cited by 123 · cited 1×
“Furthermore, higher probability eQTLs predict schizophrenia better than those with a lower probability for being an eQTL (21,28).”
The organization of the transcriptional network in specific neuronal classes
Winden, K. D., Oldham, M. C., Mirnics, K., Ebert, P. J., Swan, C. H., Levitt, P., Rubenstein, J. L., Horvath, S., & Geschwind, D. H. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.46 · Cited by 112 · cited 1×
“By finding biologically meaningful correlations, weighted correlation network analysis is perhaps the best suited analytical method to alleviate some of these concerns (52,53); yet, even this approach cannot”
MethodSelf-citationImmune system gene dysregulation in autism and schizophrenia
Michel, M., Schmidt, M. J., & Mirnics, K. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22044 · Cited by 107 · cited 1×
“Schizophrenia is a spectrum disorder rather than a single diagnosis (2) and the etiology of the disease is complex, encompassing both environmental and genetic factors (3).”
BackgroundSelf-citationA System-Level Transcriptomic Analysis of Schizophrenia Using Postmortem Brain Tissue Samples
Roussos, P., Katsel, P., Davis, K. L., Siever, L. J., & Haroutunian, V. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.704 · Cited by 92 · cited 1×
“uncertain, it appears that synaptic (7,8), mitochondrial (9,10), immune system (6,11), gamma-aminobutyric acid (GABA)ergic (12,13), and oligodendrocytic (14,15) messenger RNA (mRNA) changes are all integral parts of the disease process (1,16).”
BackgroundAnalyzing Schizophrenia by DNA Microarrays
Horváth, S., Janka, Z., & Mirnics, K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.017 · Cited by 64 · cited 3×
“uncertain, it appears that synaptic (7,8), mitochondrial (9,10), immune system (6,11), gamma-aminobutyric acid (GABA)ergic (12,13), and oligodendrocytic (14,15) messenger RNA (mRNA) changes are all integral parts of the disease process (1,16).”
BackgroundMethodSelf-citation
Cited by
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
“Thirdly, it is clear that schizophrenia is unlikely to arise from a single cause in all cases (Horvath and Mirnics, 2014; Howes and Kapur, 2014), and thus glutamate abnormalities may be present only in a subset of patients with the illness, and possibly only at a particular phase of illness in these individuals (Marsm…”
BackgroundA Single-Cell Transcriptomic Atlas of Human Neocortical Development during Mid-gestation
Polioudakis, D., de la Torre-Ubieta, L., Langerman, J., Elkins, A. G., Shi, X., Stein, J. L., Vuong, C. K., Nichterwitz, S., Gevorgian, M., Opland, C. K., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.011 · Cited by 513
New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
Yang, A., & Tsai, S.-J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081689 · Cited by 282
Arion, D., Corradi, J. P., Tang, S., Datta, D., Boothe, F., He, A., Cacace, A. M., Zaczek, R., Albright, C. F., Tseng, G., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.171 · Cited by 177
Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia
Enwright III, J. F., Huo, Z., Arion, D., Corradi, J. P., Tseng, G., & Lewis, D. A. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.216 · Cited by 109
Metadata
- Authors
- Horváth, S., & Mirnics, K.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 77
- Issue
- 1
- Pages
- 22-28
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2061550475
- Cited by
- 91
- References
- 20
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.